In a study published yesterday in the scientific journal Nature Immunology, a group at the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new genes that likely contribute to asthma, a disease that currently affects over 200...
8-Jul-2014 3:10 PM EDT
Research toward the world’s first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
17-Jun-2014 6:00 AM EDT
A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.
3-Apr-2014 3:00 PM EDT
Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema – a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.
9-Jan-2014 12:00 PM EST
A major new finding that will significantly advance efforts to create the world’s first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.
10-Sep-2013 6:25 PM EDT
La Jolla Institute for Allergy and Immunology has earned the Number 1 ranking in The Scientist magazine’s 2013 “Best Places to Work in Academia” survey of the worldwide academic research community.
8-Aug-2013 8:00 AM EDT
La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin California, Inc. (KKC), a wholly-owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (KHK), a global specialty pharmaceutical company, today announced the signing of a new agreement...
30-Jul-2013 6:00 AM EDT
Herbert A. Wertheim, O.D., D.Sc., M.D. (hc), a noted inventor, philanthropist, and optometric and visual science industry pioneer, has been elected to La Jolla Institute for Allergy and Immunology’s Board of Directors.
17-Jul-2013 6:00 AM EDT